Stock Comparison
AMGN vs LLY
Amgen Inc and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$222.66B
$1.04T
P/E (TTM)
25.6
39.1
Forward P/E
18.4
32.1
Price/Sales
5.9
13.0
Price/Book
19.1
30.6
EV/EBITDA
15.1
26.0
Dividend Yield
2.35%
0.53%
Profitability
Net Margin
20.95%
33.53%
Operating Margin
31.63%
43.92%
Return on Equity
91.50%
102.30%
Return on Assets
8.67%
20.40%
Growth (YoY)
Revenue Growth
9.50%
47.70%
Earnings Growth
64.90%
26.20%
Price & Risk
Beta
0.4
0.5
52-Week High
$417.84
$1,235.65
52-Week Low
$265.41
$679.67
Analyst Target
$374.69
$1,297.31
Compare AMGN and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.